These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2867764

  • 1. Increased insulin binding and glucose transport in white adipocytes isolated from C57B1/6 ob/ob mice treated with the thermogenic beta-adrenoceptor agonist BRL 26830.
    Young P, King L, Cawthorne MA.
    Biochem Biophys Res Commun; 1985 Dec 17; 133(2):457-61. PubMed ID: 2867764
    [Abstract] [Full Text] [Related]

  • 2. Effects of novel beta-adrenoceptor agonists on carbohydrate metabolism: relevance for the treatment of non-insulin-dependent diabetes.
    Cawthorne MA, Carroll MJ, Levy AL, Lister CA, Sennitt MV, Smith SA, Young P.
    Int J Obes; 1984 Dec 17; 8 Suppl 1():93-102. PubMed ID: 6152558
    [Abstract] [Full Text] [Related]

  • 3. Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling.
    Young PW, Cawthorne MA, Coyle PJ, Holder JC, Holman GD, Kozka IJ, Kirkham DM, Lister CA, Smith SA.
    Diabetes; 1995 Sep 17; 44(9):1087-92. PubMed ID: 7657033
    [Abstract] [Full Text] [Related]

  • 4. Improved glycemic control in C57Bl/KsJ (db/db) mice after treatment with the thermogenic beta-adrenoceptor agonist, BRL 26830.
    Carroll MJ, Lister CA, Sennitt MV, Stewart-Long N, Cawthorne MA.
    Diabetes; 1985 Nov 17; 34(11):1198-204. PubMed ID: 2864298
    [Abstract] [Full Text] [Related]

  • 5. Brown adipose tissue is a major site of glucose utilisation in C57Bl/6 ob/ob mice treated with a thermogenic beta-adrenoceptor agonist.
    Young P, Cawthorne MA, Smith SA.
    Biochem Biophys Res Commun; 1985 Jul 16; 130(1):241-8. PubMed ID: 4026829
    [Abstract] [Full Text] [Related]

  • 6. A new, highly selective murine peroxisome proliferator-activated receptor δ agonist increases responsiveness to thermogenic stimuli and glucose uptake in skeletal muscle in obese mice.
    Ngala RA, Stocker CJ, Roy AG, Hislop D, Wargent E, Bell R, Hassall DG, Harling JD, Billin AN, Willson TM, Arch JR, Cawthorne MA.
    Diabetes Obes Metab; 2011 May 16; 13(5):455-64. PubMed ID: 21272187
    [Abstract] [Full Text] [Related]

  • 7. Glucose transporter in insulin sensitive tissues of lean and obese mice. Effect of the thermogenic agent BRL 26830A.
    Le Marchand-Brustel Y, Olichon-Berthe C, Grémeaux T, Tanti JF, Rochet N, Van Obberghen E.
    Endocrinology; 1990 Dec 16; 127(6):2687-95. PubMed ID: 2249621
    [Abstract] [Full Text] [Related]

  • 8. Anti-hyperglycaemic action of BRL 26830, a novel beta-adrenoceptor agonist, in mice and rats.
    Sennitt MV, Arch JR, Levy AL, Simson DL, Smith SA, Cawthorne MA.
    Biochem Pharmacol; 1985 Apr 15; 34(8):1279-85. PubMed ID: 2859857
    [Abstract] [Full Text] [Related]

  • 9. Effect of the beta-adrenoceptor agonist BRL 26830 on fatty acid synthesis and on the activities of pyruvate dehydrogenase and acetyl-CoA carboxylase in adipose tissues of the rat.
    Wilson S.
    Biosci Rep; 1989 Feb 15; 9(1):111-7. PubMed ID: 2566340
    [Abstract] [Full Text] [Related]

  • 10. Effects of beta-adrenoceptor subtype stimulation on obese gene messenger ribonucleic acid and on leptin secretion in mouse brown adipocytes differentiated in culture.
    Deng C, Moinat M, Curtis L, Nadakal A, Preitner F, Boss O, Assimacopoulos-Jeannet F, Seydoux J, Giacobino JP.
    Endocrinology; 1997 Feb 15; 138(2):548-52. PubMed ID: 9002984
    [Abstract] [Full Text] [Related]

  • 11. Anti-obesity and anti-diabetic actions of a beta 3-adrenoceptor agonist, BRL 26830A, in yellow KK mice.
    Yoshida T, Hiraoka N, Yoshioka K, Hasegawa G, Kondo M.
    Endocrinol Jpn; 1991 Aug 15; 38(4):397-403. PubMed ID: 1687027
    [Abstract] [Full Text] [Related]

  • 12. Contrasts between the effects of zinc-α2-glycoprotein, a putative β3/2-adrenoceptor agonist and the β3/2-adrenoceptor agonist BRL35135 in C57Bl/6 (ob/ob) mice.
    Wargent ET, O'Dowd JF, Zaibi MS, Gao D, Bing C, Trayhurn P, Cawthorne MA, Arch JR, Stocker CJ.
    J Endocrinol; 2013 Feb 15; 216(2):157-68. PubMed ID: 23151357
    [Abstract] [Full Text] [Related]

  • 13. RU-486 (Mifepristone) ameliorates diabetes but does not correct deficient beta-adrenergic signalling in adipocytes from mature C57BL/6J-ob/ob mice.
    Gettys TW, Watson PM, Taylor IL, Collins S.
    Int J Obes Relat Metab Disord; 1997 Oct 15; 21(10):865-73. PubMed ID: 9347404
    [Abstract] [Full Text] [Related]

  • 14. Effects of BRL 26830, a novel beta-adrenoceptor agonist, on glucose tolerance, insulin sensitivity and glucose turnover in Zucker (fa/fa) rats.
    Smith SA, Levy AL, Sennitt MV, Simson DL, Cawthorne MA.
    Biochem Pharmacol; 1985 Jul 15; 34(14):2425-9. PubMed ID: 2861816
    [Abstract] [Full Text] [Related]

  • 15. Beta 3-adrenergic receptors are responsible for the adrenergic inhibition of insulin-stimulated glucose transport in rat adipocytes.
    Carpéné C, Chalaux E, Lizarbe M, Estrada A, Mora C, Palacin M, Zorzano A, Lafontan M, Testar X.
    Biochem J; 1993 Nov 15; 296 ( Pt 1)(Pt 1):99-105. PubMed ID: 7902704
    [Abstract] [Full Text] [Related]

  • 16. Ciglitazone, a new hypoglycemic agent. II. Effect on glucose and lipid metabolisms and insulin binding in the adipose tissue of C57BL/6J-ob/ob and -+/? mice.
    Chang AY, Wyse BM, Gilchrist BJ.
    Diabetes; 1983 Sep 15; 32(9):839-45. PubMed ID: 6354791
    [Abstract] [Full Text] [Related]

  • 17. Potentiation of the anti-obesity effect of the selective beta 3-adrenoceptor agonist BRL 35135 in obese Zucker rats by exercise.
    Santti E, Huupponen R, Rouru J, Hänninen V, Pesonen U, Jhanwar-Uniyal M, Koulu M.
    Br J Pharmacol; 1994 Dec 15; 113(4):1231-6. PubMed ID: 7889277
    [Abstract] [Full Text] [Related]

  • 18. Mitigation of obesity by BRL 26830A, a new beta-adrenoceptor agonist, in MSG obese mice.
    Yoshida T, Yoshioka K, Kamanaru K, Hiraoka N, Kondo M.
    J Nutr Sci Vitaminol (Tokyo); 1990 Feb 15; 36(1):75-80. PubMed ID: 1972962
    [Abstract] [Full Text] [Related]

  • 19. Treatment of obesity with thermogenic beta-adrenoceptor agonists: studies on BRL 26830A in rodents.
    Arch JR, Ainsworth AT, Ellis RD, Piercy V, Thody VE, Thurlby PL, Wilson C, Wilson S, Young P.
    Int J Obes; 1984 Feb 15; 8 Suppl 1():1-11. PubMed ID: 6152555
    [Abstract] [Full Text] [Related]

  • 20. Reduced maximum capacity of glycolysis in brown adipose tissue of genetically obese, diabetic (db/db) mice and its restoration following treatment with a thermogenic beta-adrenoceptor agonist.
    Young P, Cawthorne MA, Levy AL, Wilson K.
    FEBS Lett; 1984 Oct 15; 176(1):16-20. PubMed ID: 6149150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.